img

Global Leuprolide Acetate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Leuprolide Acetate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprolide Acetate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leuprolide Acetate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prostate Cancer and Precocious are the major drivers for the industry.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leuprolide Acetate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Mode of Administration, Application and Regions Listed in the Report



By Company


Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Segment by Mode of Administration
Intramuscular
Subcutaneous

Segment by Application


Prostate Cancer
Precocious
Uterine Fibroid
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Leuprolide Acetate market further
Chapter 1Product Definition, Product Mode of Administrations, Volume and Revenue analysis of Each Mode of Administration in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leuprolide Acetate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leuprolide Acetate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Leuprolide Acetate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leuprolide Acetate introduction, etc. Leuprolide Acetate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Leuprolide Acetate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Leuprolide Acetate Market Overview
1.1 Leuprolide Acetate Product Overview
1.2 Leuprolide Acetate Market Segment by Mode of Administration
1.2.1 Intramuscular
1.2.2 Subcutaneous
1.3 Global Leuprolide Acetate Market Size by Mode of Administration
1.3.1 Global Leuprolide Acetate Market Size Overview by Mode of Administration (2024-2034)
1.3.2 Global Leuprolide Acetate Historic Market Size Review by Mode of Administration (2024-2024)
1.3.3 Global Leuprolide Acetate Forecasted Market Size by Mode of Administration (2024-2034)
1.4 Key Regions Market Size Segment by Mode of Administration
1.4.1 North America Leuprolide Acetate Sales Breakdown by Mode of Administration (2024-2024)
1.4.2 Europe Leuprolide Acetate Sales Breakdown by Mode of Administration (2024-2024)
1.4.3 Asia-Pacific Leuprolide Acetate Sales Breakdown by Mode of Administration (2024-2024)
1.4.4 Latin America Leuprolide Acetate Sales Breakdown by Mode of Administration (2024-2024)
1.4.5 Middle East and Africa Leuprolide Acetate Sales Breakdown by Mode of Administration (2024-2024)
2 Global Leuprolide Acetate Market Competition by Company
2.1 Global Top Players by Leuprolide Acetate Sales (2024-2024)
2.2 Global Top Players by Leuprolide Acetate Revenue (2024-2024)
2.3 Global Top Players by Leuprolide Acetate Price (2024-2024)
2.4 Global Top Manufacturers Leuprolide Acetate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Leuprolide Acetate Market Competitive Situation and Trends
2.5.1 Leuprolide Acetate Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Leuprolide Acetate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leuprolide Acetate as of 2022)
2.7 Date of Key Manufacturers Enter into Leuprolide Acetate Market
2.8 Key Manufacturers Leuprolide Acetate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Leuprolide Acetate Status and Outlook by Region
3.1 Global Leuprolide Acetate Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Leuprolide Acetate Historic Market Size by Region
3.2.1 Global Leuprolide Acetate Sales in Volume by Region (2024-2024)
3.2.2 Global Leuprolide Acetate Sales in Value by Region (2024-2024)
3.2.3 Global Leuprolide Acetate Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Leuprolide Acetate Forecasted Market Size by Region
3.3.1 Global Leuprolide Acetate Sales in Volume by Region (2024-2034)
3.3.2 Global Leuprolide Acetate Sales in Value by Region (2024-2034)
3.3.3 Global Leuprolide Acetate Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Leuprolide Acetate by Application
4.1 Leuprolide Acetate Market Segment by Application
4.1.1 Prostate Cancer
4.1.2 Precocious
4.1.3 Uterine Fibroid
4.1.4 Others
4.2 Global Leuprolide Acetate Market Size by Application
4.2.1 Global Leuprolide Acetate Market Size Overview by Application (2024-2034)
4.2.2 Global Leuprolide Acetate Historic Market Size Review by Application (2024-2024)
4.2.3 Global Leuprolide Acetate Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Leuprolide Acetate Sales Breakdown by Application (2024-2024)
4.3.2 Europe Leuprolide Acetate Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Leuprolide Acetate Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Leuprolide Acetate Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Leuprolide Acetate Sales Breakdown by Application (2024-2024)
5 North America Leuprolide Acetate by Country
5.1 North America Leuprolide Acetate Historic Market Size by Country
5.1.1 North America Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Leuprolide Acetate Sales in Volume by Country (2024-2024)
5.1.3 North America Leuprolide Acetate Sales in Value by Country (2024-2024)
5.2 North America Leuprolide Acetate Forecasted Market Size by Country
5.2.1 North America Leuprolide Acetate Sales in Volume by Country (2024-2034)
5.2.2 North America Leuprolide Acetate Sales in Value by Country (2024-2034)
6 Europe Leuprolide Acetate by Country
6.1 Europe Leuprolide Acetate Historic Market Size by Country
6.1.1 Europe Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Leuprolide Acetate Sales in Volume by Country (2024-2024)
6.1.3 Europe Leuprolide Acetate Sales in Value by Country (2024-2024)
6.2 Europe Leuprolide Acetate Forecasted Market Size by Country
6.2.1 Europe Leuprolide Acetate Sales in Volume by Country (2024-2034)
6.2.2 Europe Leuprolide Acetate Sales in Value by Country (2024-2034)
7 Asia-Pacific Leuprolide Acetate by Region
7.1 Asia-Pacific Leuprolide Acetate Historic Market Size by Region
7.1.1 Asia-Pacific Leuprolide Acetate Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Leuprolide Acetate Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Leuprolide Acetate Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Leuprolide Acetate Forecasted Market Size by Region
7.2.1 Asia-Pacific Leuprolide Acetate Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Leuprolide Acetate Sales in Value by Region (2024-2034)
8 Latin America Leuprolide Acetate by Country
8.1 Latin America Leuprolide Acetate Historic Market Size by Country
8.1.1 Latin America Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Leuprolide Acetate Sales in Volume by Country (2024-2024)
8.1.3 Latin America Leuprolide Acetate Sales in Value by Country (2024-2024)
8.2 Latin America Leuprolide Acetate Forecasted Market Size by Country
8.2.1 Latin America Leuprolide Acetate Sales in Volume by Country (2024-2034)
8.2.2 Latin America Leuprolide Acetate Sales in Value by Country (2024-2034)
9 Middle East and Africa Leuprolide Acetate by Country
9.1 Middle East and Africa Leuprolide Acetate Historic Market Size by Country
9.1.1 Middle East and Africa Leuprolide Acetate Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Leuprolide Acetate Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Leuprolide Acetate Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Leuprolide Acetate Forecasted Market Size by Country
9.2.1 Middle East and Africa Leuprolide Acetate Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Leuprolide Acetate Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Tolmar Pharmaceuticals
10.1.1 Tolmar Pharmaceuticals Company Information
10.1.2 Tolmar Pharmaceuticals Introduction and Business Overview
10.1.3 Tolmar Pharmaceuticals Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Tolmar Pharmaceuticals Leuprolide Acetate Products Offered
10.1.5 Tolmar Pharmaceuticals Recent Development
10.2 Varian Pharmed
10.2.1 Varian Pharmed Company Information
10.2.2 Varian Pharmed Introduction and Business Overview
10.2.3 Varian Pharmed Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Varian Pharmed Leuprolide Acetate Products Offered
10.2.5 Varian Pharmed Recent Development
10.3 Avenit
10.3.1 Avenit Company Information
10.3.2 Avenit Introduction and Business Overview
10.3.3 Avenit Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Avenit Leuprolide Acetate Products Offered
10.3.5 Avenit Recent Development
10.4 Takeda Pharmaceutical
10.4.1 Takeda Pharmaceutical Company Information
10.4.2 Takeda Pharmaceutical Introduction and Business Overview
10.4.3 Takeda Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Takeda Pharmaceutical Leuprolide Acetate Products Offered
10.4.5 Takeda Pharmaceutical Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sun Pharmaceutical Industries Leuprolide Acetate Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Livzon Pharmaceutical
10.6.1 Livzon Pharmaceutical Company Information
10.6.2 Livzon Pharmaceutical Introduction and Business Overview
10.6.3 Livzon Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Livzon Pharmaceutical Leuprolide Acetate Products Offered
10.6.5 Livzon Pharmaceutical Recent Development
10.7 Beijing Biote Pharmaceutical
10.7.1 Beijing Biote Pharmaceutical Company Information
10.7.2 Beijing Biote Pharmaceutical Introduction and Business Overview
10.7.3 Beijing Biote Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Beijing Biote Pharmaceutical Leuprolide Acetate Products Offered
10.7.5 Beijing Biote Pharmaceutical Recent Development
10.8 Soho-YImIng
10.8.1 Soho-YImIng Company Information
10.8.2 Soho-YImIng Introduction and Business Overview
10.8.3 Soho-YImIng Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Soho-YImIng Leuprolide Acetate Products Offered
10.8.5 Soho-YImIng Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.9.4 AbbVie Leuprolide Acetate Products Offered
10.9.5 AbbVie Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Sanofi Leuprolide Acetate Products Offered
10.10.5 Sanofi Recent Development
10.11 Astellas Pharma
10.11.1 Astellas Pharma Company Information
10.11.2 Astellas Pharma Introduction and Business Overview
10.11.3 Astellas Pharma Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Astellas Pharma Leuprolide Acetate Products Offered
10.11.5 Astellas Pharma Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Abbott Leuprolide Acetate Products Offered
10.12.5 Abbott Recent Development
10.13 Merck
10.13.1 Merck Company Information
10.13.2 Merck Introduction and Business Overview
10.13.3 Merck Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Merck Leuprolide Acetate Products Offered
10.13.5 Merck Recent Development
10.14 Pfizer
10.14.1 Pfizer Company Information
10.14.2 Pfizer Introduction and Business Overview
10.14.3 Pfizer Leuprolide Acetate Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Pfizer Leuprolide Acetate Products Offered
10.14.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Leuprolide Acetate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Leuprolide Acetate Industrial Chain Analysis
11.4 Leuprolide Acetate Market Dynamics
11.4.1 Leuprolide Acetate Industry Trends
11.4.2 Leuprolide Acetate Market Drivers
11.4.3 Leuprolide Acetate Market Challenges
11.4.4 Leuprolide Acetate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Leuprolide Acetate Distributors
12.3 Leuprolide Acetate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intramuscular
Table 2. Major Company of Subcutaneous
Table 3. Global Leuprolide Acetate Sales by Mode of Administration 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (K Units)
Table 5. Global Leuprolide Acetate Sales Market Share in Volume by Mode of Administration (2024-2024)
Table 6. Global Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US& Million)
Table 7. Global Leuprolide Acetate Market Share in Value by Mode of Administration (2024-2024)
Table 8. Global Leuprolide Acetate Price by Mode of Administration (2024-2024) & (USD/Unit)
Table 9. Global Leuprolide Acetate Sales by Mode of Administration (2024-2034) & (K Units)
Table 10. Global Leuprolide Acetate Sales Market Share in Volume by Mode of Administration (2024-2034)
Table 11. Global Leuprolide Acetate Sales by Mode of Administration (2024-2034) & (US$ Million)
Table 12. Global Leuprolide Acetate Sales Market Share in Value by Mode of Administration (2024-2034)
Table 13. Global Leuprolide Acetate Price by Mode of Administration (2024-2034) & (USD/Unit)
Table 14. North America Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (K Units)
Table 15. North America Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US$ Million)
Table 16. Europe Leuprolide Acetate Sales (K Units) by Mode of Administration (2024-2024)
Table 17. Europe Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Leuprolide Acetate Sales (K Units) by Mode of Administration (2024-2024)
Table 19. Asia-Pacific Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US$ Million)
Table 20. Latin America Leuprolide Acetate Sales (K Units) by Mode of Administration (2024-2024)
Table 21. Latin America Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Leuprolide Acetate Sales (K Units) by Mode of Administration (2024-2024)
Table 23. Middle East and Africa Leuprolide Acetate Sales by Mode of Administration (2024-2024) & (US$ Million)
Table 24. Global Leuprolide Acetate Sales by Company (2024-2024) & (K Units)
Table 25. Global Leuprolide Acetate Sales Share by Company (2024-2024)
Table 26. Global Leuprolide Acetate Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Leuprolide Acetate Revenue Share by Company (2024-2024)
Table 28. Global Market Leuprolide Acetate Price by Company (2024-2024) & (USD/Unit)
Table 29. Global Leuprolide Acetate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Leuprolide Acetate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leuprolide Acetate as of 2022)
Table 32. Date of Key Manufacturers Enter into Leuprolide Acetate Market
Table 33. Key Manufacturers Leuprolide Acetate Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Leuprolide Acetate Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Leuprolide Acetate Sales by Region (2024-2024) & (K Units)
Table 37. Global Leuprolide Acetate Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Leuprolide Acetate Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Leuprolide Acetate Sales Market Share in Value by Region (2024-2024)
Table 40. Global Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 41. Global Leuprolide Acetate Sales by Region (2024-2034) & (K Units)
Table 42. Global Leuprolide Acetate Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Leuprolide Acetate Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Leuprolide Acetate Sales Market Share in Value by Region (2024-2034)
Table 45. Global Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Leuprolide Acetate Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Leuprolide Acetate Sales by Application (2024-2024) & (K Units)
Table 48. Global Leuprolide Acetate Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Leuprolide Acetate Sales Market Share in Value by Application (2024-2024)
Table 51. Global Leuprolide Acetate Price by Application (2024-2024) & (USD/Unit)
Table 52. Global Leuprolide Acetate Sales by Application (2024-2034) & (K Units)
Table 53. Global Leuprolide Acetate Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Leuprolide Acetate Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Leuprolide Acetate Sales Market Share in Value by Application (2024-2034)
Table 56. Global Leuprolide Acetate Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Leuprolide Acetate Sales by Application (2024-2024) (K Units)
Table 58. North America Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Leuprolide Acetate Sales by Application (2024-2024) (K Units)
Table 60. Europe Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Leuprolide Acetate Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Leuprolide Acetate Sales by Application (2024-2024) (K Units)
Table 64. Latin America Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Leuprolide Acetate Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Leuprolide Acetate Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Leuprolide Acetate Sales by Country (2024-2024) & (K Units)
Table 68. North America Leuprolide Acetate Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Leuprolide Acetate Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Leuprolide Acetate Sales Market Share in Value by Country (2024-2024)
Table 71. North America Leuprolide Acetate Sales by Country (2024-2034) & (K Units)
Table 72. North America Leuprolide Acetate Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Leuprolide Acetate Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Leuprolide Acetate Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Leuprolide Acetate Sales by Country (2024-2024) & (K Units)
Table 76. Europe Leuprolide Acetate Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Leuprolide Acetate Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Leuprolide Acetate Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Leuprolide Acetate Sales by Country (2024-2034) & (K Units)
Table 80. Europe Leuprolide Acetate Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Leuprolide Acetate Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Leuprolide Acetate Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Leuprolide Acetate Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Leuprolide Acetate Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Leuprolide Acetate Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Leuprolide Acetate Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Leuprolide Acetate Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Leuprolide Acetate Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Leuprolide Acetate Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Leuprolide Acetate Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Leuprolide Acetate Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Leuprolide Acetate Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Leuprolide Acetate Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Leuprolide Acetate Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Leuprolide Acetate Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Leuprolide Acetate Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Leuprolide Acetate Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Leuprolide Acetate Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Leuprolide Acetate Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Leuprolide Acetate Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Leuprolide Acetate Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Leuprolide Acetate Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Leuprolide Acetate Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Leuprolide Acetate Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Leuprolide Acetate Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Leuprolide Acetate Sales Market Share in Value by Country (2024-2034)
Table 107. Tolmar Pharmaceuticals Company Information
Table 108. Tolmar Pharmaceuticals Introduction and Business Overview
Table 109. Tolmar Pharmaceuticals Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 110. Tolmar Pharmaceuticals Leuprolide Acetate Product
Table 111. Tolmar Pharmaceuticals Recent Development
Table 112. Varian Pharmed Company Information
Table 113. Varian Pharmed Introduction and Business Overview
Table 114. Varian Pharmed Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Varian Pharmed Leuprolide Acetate Product
Table 116. Varian Pharmed Recent Development
Table 117. Avenit Company Information
Table 118. Avenit Introduction and Business Overview
Table 119. Avenit Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Avenit Leuprolide Acetate Product
Table 121. Avenit Recent Development
Table 122. Takeda Pharmaceutical Company Information
Table 123. Takeda Pharmaceutical Introduction and Business Overview
Table 124. Takeda Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Takeda Pharmaceutical Leuprolide Acetate Product
Table 126. Takeda Pharmaceutical Recent Development
Table 127. Sun Pharmaceutical Industries Company Information
Table 128. Sun Pharmaceutical Industries Introduction and Business Overview
Table 129. Sun Pharmaceutical Industries Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Sun Pharmaceutical Industries Leuprolide Acetate Product
Table 131. Sun Pharmaceutical Industries Recent Development
Table 132. Livzon Pharmaceutical Company Information
Table 133. Livzon Pharmaceutical Introduction and Business Overview
Table 134. Livzon Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Livzon Pharmaceutical Leuprolide Acetate Product
Table 136. Livzon Pharmaceutical Recent Development
Table 137. Beijing Biote Pharmaceutical Company Information
Table 138. Beijing Biote Pharmaceutical Introduction and Business Overview
Table 139. Beijing Biote Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Beijing Biote Pharmaceutical Leuprolide Acetate Product
Table 141. Beijing Biote Pharmaceutical Recent Development
Table 142. Soho-YImIng Company Information
Table 143. Soho-YImIng Introduction and Business Overview
Table 144. Soho-YImIng Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. Soho-YImIng Leuprolide Acetate Product
Table 146. Soho-YImIng Recent Development
Table 147. AbbVie Company Information
Table 148. AbbVie Introduction and Business Overview
Table 149. AbbVie Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. AbbVie Leuprolide Acetate Product
Table 151. AbbVie Recent Development
Table 152. Sanofi Company Information
Table 153. Sanofi Introduction and Business Overview
Table 154. Sanofi Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Sanofi Leuprolide Acetate Product
Table 156. Sanofi Recent Development
Table 157. Astellas Pharma Company Information
Table 158. Astellas Pharma Introduction and Business Overview
Table 159. Astellas Pharma Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 160. Astellas Pharma Leuprolide Acetate Product
Table 161. Astellas Pharma Recent Development
Table 162. Abbott Company Information
Table 163. Abbott Introduction and Business Overview
Table 164. Abbott Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 165. Abbott Leuprolide Acetate Product
Table 166. Abbott Recent Development
Table 167. Merck Company Information
Table 168. Merck Introduction and Business Overview
Table 169. Merck Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 170. Merck Leuprolide Acetate Product
Table 171. Merck Recent Development
Table 172. Pfizer Company Information
Table 173. Pfizer Introduction and Business Overview
Table 174. Pfizer Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 175. Pfizer Leuprolide Acetate Product
Table 176. Pfizer Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Leuprolide Acetate Market Trends
Table 180. Leuprolide Acetate Market Drivers
Table 181. Leuprolide Acetate Market Challenges
Table 182. Leuprolide Acetate Market Restraints
Table 183. Leuprolide Acetate Distributors List
Table 184. Leuprolide Acetate Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Leuprolide Acetate Product Picture
Figure 2. Global Leuprolide Acetate Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Leuprolide Acetate Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Leuprolide Acetate Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Intramuscular
Figure 6. Global Intramuscular Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Subcutaneous
Figure 8. Global Subcutaneous Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Leuprolide Acetate Sales by Mode of Administration (2024-2034) & (US$ Million)
Figure 10. Global Leuprolide Acetate Sales Market Share by Mode of Administration in 2022 & 2034
Figure 11. North America Leuprolide Acetate Sales Market Share in Volume by Mode of Administration in 2022
Figure 12. North America Leuprolide Acetate Sales Market Share in Value by Mode of Administration in 2022
Figure 13. Europe Leuprolide Acetate Sales Market Share in Volume by Mode of Administration in 2022
Figure 14. Europe Leuprolide Acetate Sales Market Share in Value by Mode of Administration in 2022
Figure 15. Asia-Pacific Leuprolide Acetate Sales Market Share in Volume by Mode of Administration in 2022
Figure 16. Asia-Pacific Leuprolide Acetate Sales Market Share in Value by Mode of Administration in 2022
Figure 17. Latin America Leuprolide Acetate Sales Market Share in Volume by Mode of Administration in 2022
Figure 18. Latin America Leuprolide Acetate Sales Market Share in Value by Mode of Administration in 2022
Figure 19. Middle East and Africa Leuprolide Acetate Sales Market Share in Volume by Mode of Administration in 2022
Figure 20. Middle East and Africa Leuprolide Acetate Sales Market Share in Value by Mode of Administration in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Leuprolide Acetate Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Leuprolide Acetate Revenue in 2022
Figure 23. Leuprolide Acetate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Prostate Cancer
Figure 25. Global Prostate Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Precocious
Figure 27. Global Precocious Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Uterine Fibroid
Figure 29. Global Uterine Fibroid Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Leuprolide Acetate Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Leuprolide Acetate Sales Market Share by Application in 2022 & 2034
Figure 34. North America Leuprolide Acetate Sales Market Share in Volume by Application in 2022
Figure 35. North America Leuprolide Acetate Sales Market Share in Value by Application in 2022
Figure 36. Europe Leuprolide Acetate Sales Market Share in Volume by Application in 2022
Figure 37. Europe Leuprolide Acetate Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Leuprolide Acetate Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Leuprolide Acetate Sales Market Share in Value by Application in 2022
Figure 40. Latin America Leuprolide Acetate Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Leuprolide Acetate Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Leuprolide Acetate Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Leuprolide Acetate Manufacturing Cost Structure
Figure 45. Leuprolide Acetate Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed